Assignee
X4 PHARMACEUTICALS INC
US·16 granted patents·18 pending applications·59 citations·filing 2016–2025
Top patents by PatentIndex Score
34 records- 0197US10548889B1Compositions of CXCR4 inhibitors and methods of preparation and useX4 PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·18 cites·12 claims
- 0296US11672793B2Compositions of CXCR4 inhibitors and methods of preparation and useX4 PHARMACEUTICALS INC·Filed 2021·Granted Jun 13, 2023·3 cites·21 claims
- 0396US11045461B2Compositions of CXCR4 inhibitors and methods of preparation and useX4 PHARMACEUTICALS INC·Filed 2019·Granted Jun 29, 2021·8 cites·21 claims
- 0495US10759796B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·6 cites·26 claims
- 0594US12115156B2Compositions of CXCR4 inhibitors and methods of preparation and useX4 PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·1 cites·18 claims
- 0693US10610527B2Methods for treating immunodeficiency diseaseX4 PHARMACEUTICALS INC·Filed 2016·Granted Apr 7, 2020·13 cites·16 claims
- 0792US11306088B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2020·Granted Apr 19, 2022·2 cites·21 claims
- 0887US2025228843A1Compositions of cxcr4 inhibitors and methods of preparation and useX4 PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0986US11219621B2Methods for treating immunodeficiency diseaseX4 PHARMACEUTICALS INC·Filed 2020·Granted Jan 11, 2022·2 cites·19 claims
- 1086US10953003B2Methods for treating cancerX4 PHARMACEUTICALS INC·Filed 2016·Granted Mar 23, 2021·5 cites·14 claims
- 1183US2024150350A1Cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1281US10988465B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted Apr 27, 2021·1 cites·22 claims
- 1379US2025152575A1Methods for treating immunodeficiency diseaseX4 PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1478US11780837B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2022·Granted Oct 10, 2023·0 cites·19 claims
- 1570US2022257586A1Methods for treating immunodeficiency diseaseX4 PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1668US2025339423A1Methods for treating neutropeniaX4 PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1767US12285424B2Methods for treating neutropeniaX4 PHARMACEUTICALS INC·Filed 2022·Granted Apr 29, 2025·0 cites·8 claims
- 1865US12377090B1Methods for treating neutropeniaX4 PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·0 cites·28 claims
- 1964US2021363139A1Cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2061US2025236604A1Synthesis of mavorixafor and intermediates thereofX4 PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2160US2025361307A1Combination therapies for treating hyperproliferative disordersX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2260US2026053790A1Treatments for conditions involving increased il-6 levelsX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2358US2025041292A1Methods for treating primary immunodeficiencyX4 PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2456US2025326753A1Dual cxcr4-btk inhibitorsX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2555US11337969B2Methods for treating cancerX4 PHARMACEUTICALS INC·Filed 2017·Granted May 24, 2022·0 cites·23 claims
- 2650US2022017487A1Deuterated compounds and uses thereofX4 PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2749US2020138804A1Methods for treating cancerX4 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2847US2021025895A1Cancer serum biomarkers and methods of use thereofX4 PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2946US2021009557A1Acyclic cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3043US11332470B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted May 17, 2022·0 cites·17 claims
- 3143US2021349099A1Cancer biomarkers and methods of use thereofX4 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3241US2019030023A1Methods for treating cancerX4 PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3339US11357742B2Methods for treating cancerX4 PHARMACEUTICALS INC·Filed 2016·Granted Jun 14, 2022·0 cites·16 claims
- 3439US2023346772A1Combination treatments for waldenstrom's macroglobulinemiaX4 PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when X4 PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →